This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Amgen Inc., Cytokinetics, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,076 
1 out of 261 
Years Active: 2022
Title: Alexander Oblezov: Innovator in Pharmaceutical Chemistry
Introduction
Alexander Oblezov is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on omecamtiv mecarbil.
Latest Patents
Oblezov holds a patent for "Salts and crystal forms of omecamtiv mecarbil." This patent provides free base crystalline forms, crystalline salts, and amorphous salts of omecamtiv mecarbil, showcasing his innovative approach to drug formulation.
Career Highlights
Throughout his career, Oblezov has worked with prominent companies in the biotechnology sector, including Cytokinetics, Inc. and Amgen Inc. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
Oblezov has collaborated with esteemed colleagues such as Henry Morrison and Sheng Cui. These partnerships have contributed to his success and the advancement of his research.
Conclusion
Alexander Oblezov's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions continue to influence the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile